AbCellera
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Recent news mentioning AbCellera
- — AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity
- — Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
- — AbCellera (ABCL) Q2 2026 Earnings Call Transcript
- — AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
- — Apple, Sionna, AbCellera, Sandisk, SpaceX, Berkshire, and More Stocks That Explain Today’s Market